(redirected from Bifidobacterium)
Also found in: Dictionary, Medical, Encyclopedia, Wikipedia.
Related to Bifidobacterium: lactobacillus, Bifidobacterium bifidum
Graphic Thesaurus  🔍
Display ON
Animation ON
  • adj

Words related to bifid

divided into two lobes

References in periodicals archive ?
Bifidobacterium lactis improved blood sugar control, (41)
Bifidobacterium septicemia associated with postoperative probiotic therapy in a neonate with omphalocele.
para]]**Formulated to provide at least 10 billion live cells of Lactobacillus plantarum 299V per capsule and 2 billion live cells of Bifidobacterium lactis SD-5674 per capsule if continuously stored in a cool, dry place at or below 77AF (25AC) and consumed prior to expiration date.
Breast-fed infants had more than twice the number of Bifidobacterium cells in their stool, compared with formula-fed babies in a 2011 study.
The three predominant genera in EWG were Blautia, Anaerostrpes and Oscillibacter whereas those in IWG were Bifidobacterium, Blautia and Clostridium_g4.
Make sure that at least some of the probiotics you take are high in Bifidobacterium or Lactobacillus bacteria.
Bifidobacteriumlactis is acid tolerant species and hence, is the species of bifidobacterium most commonly used in acidic foods (Figure 2) [25].
A viable cell count of the bifidobacterium at 60 days totaled about 90% of the initial cell count, regardless of whether prebiotics were added to the product.
2009) also suggested that children who developed allergy were significantly less colonization of lactobacilli and Bifidobacterium adolescentis during the first 2 months of age.
Taken once-daily by mouth, Provella tablets contain a proprietary blend of six bacteria strains that include: Lactobacillus acidophilus, Lactobacillus plantarum, Lactobacillus rhamnosus, Lactobacillus fermentum, Lactobacillus reuteri, and Bifidobacterium bifidum.
The best-studied probiotic in the treatment of IBS is Bifidobacterium infantis.
By far the best-studied probiotic in the treatment of IBS is Bifidobacterium infantis.
Specific topics include the current status of Bifidobacterium gene manipulation technologies, oxidative stress and oxygen metabolism in lactic acid bacteria, lactococcal bacteriocins, producing optically pure lactic acid for biplastics, and anti-hypertensive metabolites from lactic acid bacteria.
Bifidobacterium and Lactobacillus species appear after the first weeks of life and the former constitute the predominant bacterial species in the infant gut (2-4).
today announced that they have concluded an option agreement concerning APS001, a novel anticancer agent currently under development at Anaeropharma Science that utilizes characteristic features of Bifidobacterium longum, as well as an agreement concerning the discovery of novel anticancer agents that utilize Bifidobacterium as a drug delivery system.